Antonio Cittadini is a Specialist in Cardiology, Director of the Division of Internal Medicine, Metabolism & Rehabilitation, and Professor of Internal Medicine at the Federico II University Hospital, Naples, Italy. He is also the Director and Chief of the Steering Committee of the Italian Registry of CHF patients called T.O.S.Ca. In addition, he is the winner of the Grant for Growth and Innovation, 2016. His scientific career and publications have been mainly devoted to secondary prevention in post-infarction and chronic heart failure patients. He is currently developing international collaborations focused on the identification of biomarkers that may improve cardiovascular risk assessment for primary and secondary prevention. Furthermore, he has also a particular interest in developing cardiovascular prevention strategies for patients with cancer and developing specific protocols for patients with COPD/pulmonary hypertension and diabetes. His major research interests include endocrine comorbidities in heart failure; cardiovascular endocrinology; and the role of growth hormone and insulin-like growth factor-1 in cardiovascular physiology and as potential therapeutic agents in cardiac diseases.